Cure SMA Annual Revenue, Competitors, Number of Employees and Funding
- Cure SMA has 76 Employees.
- Cure SMA grew their employee count by 3% last year.
- Cure SMA currently has 1 job openings.
Cure SMA Competitors
|Competitor Name||Revenue||Number of Employees||Employee Growth||Total Funding|
|Chicago Youth C...||N/A||125||0%||N/A|
|The American As...||N/A||58||N/A||N/A|
What Is Cure SMA?
Cure SMA is dedicated to the treatment and cure of spinal muscular atrophy (SMA)a disease that takes away a person's ability to walk, eat, or breathe. It is the number one genetic cause of death for infants. Since 1984, we've directed and invested in comprehensive research that has shaped the scientific community's understanding of SMA. We are currently on the verge of breakthroughs in treatment that will strengthen our children's bodies, extend life, and lead to a cure. We have deep expertise in every aspect of SMAfrom the day-to-day realities to the nuances of care optionsand until we have a cure, well do everything we can to support children and families affected by the disease. Cure SMA is a non-profit organization which has funded and directed over $75 million for leading SMA research programs. We have 34 Chapters throughout the United States and over 115,000 members and supporters. We also host the world's largest Annual SMA Conference with over 1,500 families and researchers from around the world in attendance. Learn more about how you can help us reach a treatment and cure at www.cureSMA.org.keywords:Biotechnology,Healthcare,Pharmaceuticals
Number of Employees
Employee Growth %
|Maynard Friesz||Vice President Of Policy & Advocacy|
|Michelle Pantoja||Marketing Manager||Email Available|
|Cole Jacobson||Director Of Development|
|Nancy Cardea||Vice President, Compliance & Privacy||Email Available|
|Jaimie Vickery||Vice President, Policy and Advocacy||Email Available|
|Eileen Venedam||Events and Family Support Manager||Email Available|
|Shannon O'Brien||Director, Events And Family Support||Email Available|
|Sherryl Dunning||Accounting Manager||Email Available|
|Debbie Cuevas||President Greater Ny Chapter|
|Sara Lipscomb||Manager, Events and Family Support||Email Available|
Cure SMA News
Cure SMA hosted a recent webinar with representatives from the FDA and AveXis — the company that originally developed Zolgensma, now ...
The biopharmaceutical company Cytokinetics and the nonprofit organization Cure SMA have announced a renewal of their partnership.
27, 2019 (GLOBE NEWSWIRE) -- Cure SMA and Cytokinetics (Nasdaq:CYTK) today announced the renewal of their partnership to increase ...